Project: Innovative Diagnostic RNA sequencing Platform to improve ovarian cancer outcomes
OneRNA4OvaCure aims at seizing a major market opportunity by setting up a new rational method using an innovative RNA sequencing platform (OneRNA) to select the most effective treatment for Ovarian Cancer patients, with a strong focus on immune therapies. OneRNA4OvaCure will deliver an optimized RNA sequencing platform able to identify and quantify all expressed ovarian cancer drug targets and gene expression signatures that could guide treatment decisions.
| Acronym | OneRNA4OvaCure (Reference Number: 10591) |
| Duration | 01/09/2016 - 01/09/2019 |
| Project Topic | Biological Sciences / Technologies |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 5 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 24596 | Genomic Expression ApS | Coordinator | Denmark |
| 24597 | OvaCure | Partner | Denmark |
| 24598 | PubGene AS | Partner | Norway |